NASDAQ: CSBR - Champions Oncology, Inc.

Lønnsomhet i seks måneder: +71.81%
Utbytte: 0.00%
Sektor: Healthcare

Kampanjeplan Champions Oncology, Inc.


Om selskapet Champions Oncology, Inc.

Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process.

flere detaljer
In addition, it offers Lumin Bioinformatics, a dynamic analytic and visualization software that empowers cancer biologists to harness the power of computational science in a convenient and sophisticated tool. The company markets its products through internet, word of mouth, and sales force to patients and physicians. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.

IPO date 2003-01-10
ISIN US15870P3073
Industry Life Sciences Tools & Services
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.championsoncology.com
Цена ао 5.02
Prisendring per dag: +3.09% (8.1)
Prisendring per uke: +11.26% (7.505)
Prisendring per måned: +93.74% (4.31)
Prisendring over 3 måneder: +76.91% (4.72)
Prisendring over seks måneder: +71.81% (4.86)
Prisendring per år: +48.58% (5.6199)
Prisendring over 3 år: +3.21% (8.09)
Prisendring over 5 år: +52.09% (5.49)
Prisendring over 10 år: 0% (8.35)
Prisendring siden begynnelsen av året: +83.52% (4.55)

Undervurdering

Navn Betydning Karakter
P/S 1.33 9
P/BV -35.03 0
P/E 197.15 1
EV/EBITDA -14.14 0
Total: 4.63

Effektivitet

Navn Betydning Karakter
ROA, % -24.08 0
ROE, % -532.46 0
Total: 0

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 0 0
Total: 0

Plikt

Navn Betydning Karakter
Debt/EBITDA -1.47 10
Total: 9.8

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % 56.25 7
Lønnsomhet Ebitda, % 1540.91 10
Lønnsomhet EPS, % 221.98 10
Total: 7.4

ETF Dele, % Lønnsomhet for året, % Utbytte, %
iShares Micro-Cap ETF 0.00839 17.09 1.54048



Veileder Stillingstittel Betaling Fødselsår
Dr. Ronnie Morris M.D. CEO & Director 600k 1966 (59 år)
Mr. David Barry Miller M.B.A. Chief Financial Officer 285k 1969 (56 år)
Mr. Brady Davis President N/A 1969 (56 år)
Dr. Maria Mancini Ph.D. Chief Operating Officer N/A
Mr. Arthur Hanson Vice President of Technology N/A
Ms. Rachel A. Bunting M.B.A., M.S., MBA, MS Vice President of Global Marketing N/A
Mr. David DeOrnellis BS, CMAR, CPIA, RLATG Executive Vice President of Global Laboratory Operations N/A
Dr. Michael Ritchie M.B.A., Ph.D. Chief Commercial Officer N/A
Dr. Karin Abarca Heidemann Ph.D. Executive Vice President of Global Scientific Operations N/A
Dr. Marianna Zipeto Ph.D. Executive Vice President of Commercial, Research Services & Partnering N/A

Adresse: United States, Hackensack. NJ, One University Plaza - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.championsoncology.com